Numbness persists in patient after four years of injections
A high-risk multiple myeloma diagnosis transformed one patient’s life in December 2020. Now enrolled in a Phase 2 clinical trial, they continue to experience persistent numbness even after four years of treatment.
18 hours ago
2 mins read